Furthermore, CD56 downregulation, a hallmark of t(11;14)-positive MM [9], was not evident in AL amyloidosis, suggesting disease-specific differences in plasma cell phenotype. The gene discussed is NCAM1; the disease is Miyoshi myopathy.